The Damon Runyon Cancer Research Foundation's Annual Breakfast brings together brilliant investors and the nation's top young scientists to raise money for innovative cancer research. Hosts include Emmy Award-winning sitcom producer and director James Burrows (http://www.imdb.com/name/nm0123273/) and pioneers in alternative investment, John Angelo and Michael Gordon of Angelo, Gordon & Co. (http://www.angelogordon.com/) Guests include prominent New York business, scientific, entertainment and philanthropic personalities.
Advertisement
WHAT:
Damon Runyon Cancer Research Foundation's Annual Breakfast
WHEN:
Wednesday May 28th, 7.30 AM- 9.30AM
Advertisement
WHERE:
The Rainbow Room
HOSTS:
James Burrows - Producer and Director, Cheers, Frasier, Will & Grace
Michael Gordon - Chief Operating Officer, Chief Investment Officer, Angelo, Gordon & Co.
HONOREE:
John M. Angelo - Chief Executive Officer, Angelo Gordon & Co.
SPEAKERS:
Damon Runyon Innovation Award Winners (3) will present the latest progress of their unique "high risk, high return" cancer research projects.
GUESTS AND BOARD MEMBERS INCLUDE:
Dale Frey - Retired Chairman of the Board and President, General Electric & Co. (Damon Runyon Board Chairman)
Ken Langone - Investment banker and financial backer of The Home Depot; former director of the New York Stock Exchange (Damon Runyon Vice Chairman, Board Development)
Scott Greenstein - President, Sirius Satellite Radio (Damon Runyon Board Director)
David Livingston, MD - Deputy Director, Dana-Farber/Harvard Cancer Center (Damon Runyon Vice Chairman, Scientific Programs)
Larry Bossidy - Retired CEO, Honeywell
Michael Eisner - Former Chairman and CEO, Walt Disney Company
The Damon Runyon Cancer Research Foundation invests exclusively in top young scientists, recruiting the best new minds into cancer research and seeding their bold ideas. The Foundation offers an alternative to programs supported by the NIH and large organizations, which typically favor senior scientists with established track records. The Foundation aims to bring top emerging scientists to cancer research because it believes that the greatest breakthroughs will come from the imaginative and creative talents of young minds.
Since its founding in 1946, the Foundation has invested over $200 million and funded more than 3,000 young scientists. Eleven scientists supported by the Foundation have received the Nobel Prize, and others are heads of cancer centers and leaders of renowned research programs. The Foundation currently is funding more than 120 scientists at leading medical centers and research institutions. This year, it will invest approximately $10 million in outstanding young minds.
100% of all direct donations are used to support scientific research. Its administrative and fundraising costs are paid from its Broadway Tickets Service and endowment. www.damonrunyon.org
CONTACT: Catherine Bright of the Damon Runyon Cancer Research Foundation, +1-212 455 0506, Mobile: +1-917 496 9166, [email protected]
/PRNewswire-USNewswire -- May 14/
SOURCE Damon Runyon Cancer Research Foundation
